F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/Ut8dnTC
via IFTTT Birth Control and Family Planning, Drugs (Pharmaceuticals) The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women